T0	Participants 89 108	Helicobacter pylori
T1	Participants 403 445	6-year period, patients with persistent H.
T2	Participants 446 530	pylori infection following omeprazole-clarithromycin-amoxicillin eradication therapy
T3	Participants 947 1000	95 randomized patients, 88 (93%) completed the study.